Yang Chen-Chang, Jick Susan S, Jick Hershel
Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Br J Clin Pharmacol. 2002 Jan;53(1):101-5. doi: 10.1046/j.0306-5251.2001.01523.x.
To evaluate the association between current statin use and the risk of idiopathic venous thromboembolism (VTE).
A population-based retrospective follow-up with a nested case-control analysis using the General Practice Research Database.
There were 72 cases of idiopathic VTE. Using normolipidaemic nonuse as the reference group, the adjusted relative risks for idiopathic VTE for current/recent statin use, past statin use, past other lipid-lowering drug use, and hyperlipidaemic nonuse were 0.8 (0.3, 2.7), 2.4 (0.6, 10.0), 1.8 (0.4, 7.4), and 0.9 (0.4, 2.0) in the follow-up analysis, and were 1.1 (0.3, 4.3), 3.7 (0.6, 24.1), 2.0 (0.3, 11.6), and 0.4 (0.2, 1.2) in the case-control analysis.
Current statin use was not associated with a reduced risk of idiopathic VTE.
评估当前使用他汀类药物与特发性静脉血栓栓塞症（VTE）风险之间的关联。
基于人群的回顾性随访，并使用全科医学研究数据库进行巢式病例对照分析。
有72例特发性VTE病例。在随访分析中，以血脂正常未使用者作为参照组，当前/近期使用他汀类药物、过去使用他汀类药物、过去使用其他降脂药物以及血脂异常未使用者发生特发性VTE的校正相对风险分别为0.8（0.3，2.7）、2.4（0.6，10.0）、1.8（0.4，7.4）和0.9（0.4，2.0）；在病例对照分析中，上述风险分别为1.1（0.3，4.3）、3.7（0.6，24.1）、2.0（0.3，11.6）和0.4（0.2，1.2）。
当前使用他汀类药物与特发性VTE风险降低无关。
